© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Streptomycin Sulfate – Injection Grade falls under the category of aminoglycoside antibiotics. Its molecular formula reads C21H39N7O12·H2SO4 and its structure features streptidine, streptose, and N-methyl-L-glucosamine, which link together through glycosidic bonds. This arrangement gives the molecule its antibacterial properties that have proven useful in healthcare for decades, especially for targeting infections that resist other medications. Injection grade refers to a level of purity and absence of contaminants necessary for direct administration into the human body. This is not a bulk chemical poured into cleaning agents or perfumes. Marked under HS Code 2941.10, Streptomycin Sulfate – Injection Grade shows up in pharmaceutical supply chains and regulatory listings worldwide.
Streptomycin Sulfate – Injection Grade appears as a white to off-white crystalline powder. The texture remains fine, with crystals forming tiny, solid grains that sometimes seem pearlescent under a microscope. It dissolves well in water, often forming a clear, colorless solution ready for medical use. When poured out as a dry powder, the density averages around 0.6–0.8 g/cm³, but after reconstitution with sterile water, it suspends smoothly with no clumping or settling, a crucial feature for maintaining accurate dosages during preparation. The strong polarity of the sulfate group translates into this ready solubility, as someone who has handled both cheap imitations and pharmaceutical-grade powders can attest. The difference shows up clearly in the clarity of an injectable solution and the absence of gritty undissolved particles.
The antibiotic’s backbone consists of a cyclohexane ring attached to a six-carbon amino sugar, while sulfate counters the charge for stability and water solubility. Analytical standards demand careful checks for residual solvents, binding moisture, and particulate matter, as even small contaminants can trigger adverse patient reactions. Pharmacopoeial specifications list purity above 98% and endotoxin levels below critical thresholds. Experienced formulators remind everyone that exact compliance depends on handling—poor storage leads to degradation, producing breakdown products that neither cure infection nor pass lab analysis. Organoleptic characteristics, including a slight odor and a bland taste if accidentally sampled, also suggest the substance’s suitability for sterile injections over raw materials suitable for industrial use.
Streptomycin Sulfate earns its stripes as both lifesaver and source of risk. In powdered form, inhalation or contact may cause irritation or sensitization, especially with repeated exposure. In solution, accidental spillages demand quick cleanup and proper protective equipment. Distributed material often carries clear hazard warnings because aminoglycosides can cause auditory or renal complications if misused—the same strength that eliminates bacteria can harm human tissue under the wrong conditions. Regular training in pharmaceutical labs stresses the importance of gloves, masks, and splash goggles, not just as formalities, but as non-negotiable barriers. Those who ignore protocols find out quickly through accidental exposure that the guidelines reflect real danger. Material Safety Data Sheets point out that fire, while unlikely, produces hazardous decomposition, and reactivity with strong oxidizers or acids remains a theoretical concern in regulated environments. Experienced handlers store the compound at low temperatures, away from moisture and direct sunlight.
Raw streptomycin production involves fermentation by the bacteria Streptomyces griseus, a soil-dweller first isolated nearly 80 years ago. The conversion from crude filtrate to purified sulfate salt incorporates numerous purification steps: precipitation, solvent extraction, drying, and analytical examination. Finished injection-grade product only clears the last gate after batch documentation, validated tests, and release by qualified personnel. As expected under global regulatory harmonization, this antibiotic’s listing under international treaties and export regulations ties its movement to strict paperwork trails. Some users mistakenly believe they can swap raw material or technical grade streptomycin for medical use, not realizing that impurities at this stage can ruin entire production runs. Sourcing reputable raw materials has occupied a central place in pharmaceutical manufacturing, with whip-smart procurement teams able to recount stories of batches rejected due to minuscule differences in ash content or color.
The journey from powdered solid to ready-to-inject medication mirrors the complexity of modern medicine itself. Streptomycin Sulfate – Injection Grade finds its primary place in treating tuberculosis and select gram-negative infections in patients allergic to other drugs. Antibiotic stewardship remains a huge problem. Resistance to aminoglycosides like streptomycin threatens to erode the climbing survival rates witnessed during past decades. Instead of turning to newer drugs for every resistant bug, careful control over prescribing, batch quality checks, and continued investment in detection methods stand out as sustainable answers. Waste disposal programs for expired stock, protective education for clinical staff, and robust global supply chain monitoring support the safe ongoing use of this classic antibiotic. Those engaged in product handling, from procurement down to line operators, carry a responsibility to treat Streptomycin Sulfate – Injection Grade as both a chemical and a medical material, balancing the benefits of bacterial eradication against the risk of harm from careless use.
